I looked at both. I think that both are excellent, but there are differences. Here's a review that discusses all the technical and outcome differences:
Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between optionsIt is unfortunately very rare that randomized comparative trials are made, but
there was one done at William Beaumont Hospital comparing LDR to HDR brachy. They found that the rates of late term/chronic urinary and rectal toxicity were similar, but that "The impotence rate was decreased by half with HDR." Of those who were fully potent before therapy, 82% remained fully potent after HDR, but only 41% remained fully potent after LDR. Rates of acute urinary and rectal toxicity were lower with HDR.
Dr . Demanes's 8-year HDR results were similar to the William Beaumont Hospital results.Arguably, the results are better from Peter Grimm and the Seattle doctors than for the brachy docs at William Beaumont. In fact, in reviewing the Seattle
early results vs their
current results, I was struck by how much better they are doing now. There seems to be a sharp learning curve with seeds and wide disparities in the results from one place to another. So, comparing the best to the best (
Katz for SBRT,
Seattle for LDR &
Demanes for HDR) monadically (not strictly kosher)...
Maintenance of sexual potency: SBRT (6 yrs) - 75% HDR (8 yrs) - 82% LDR (7 yrs) - 76% (among the most potent, 56% overall)
Acute Grade 2 or higher urinary toxicity: SBRT - 4% HDR - 13% LDR-43% urinary retention
Biochemical recurrence-free survival (bRFS) for low risk patients: SBRT (6 yr) - 97% HDR (8 yr) - 99% LDR (12-yr) - 97%
The reason that SBRT and HDR are able to achieve such great results with low net radiation doses is that they take advantage of the low alpha-beta ratio of prostate cancer - it's killed more efficiently by higher dose rates. LDR accomplishes the same thing with brute force- the total dose is delivered continuously and is 3-4x higher. That's also why the urinary retention rate is so much higher. But that is typically a transient and manageable SE. Late term effects are similar for all of those treatments and are very low.
I think LDR gives great results in Seattle, MSK and a few other places, and not so good results elsewhere. LDR is quicker than HDR, and considerably less costly and less bother.
I considered going to Al Taira in Mountain View for LDR, but UCLA, which offers HDR and SBRT is 10 minutes from home. I chose SBRT over HDR because I preferred no hospital stays. Radiobiologically they are identical (SBRT was designed to mimic HDR), and their oncological and toxicity outcomes are identical as well.